FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

85313011000036102: Qlaira (dienogest 3 mg + estradiol valerate 2 mg) tablet (trade product unit of use)

Status: current, Defined. Date: 31-May 2010. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4140271000168115 Qlaira (dienogest 3 mg + estradiol valerate 2 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4140281000168117 Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet en Synonym Active Case sensitive Australian Medicines Terminology module
4143221000168112 Qlaira (dienogest 3 mg + oestradiol valerate 2 mg) tablet en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet has manufactured dose form tablet true Inferred relationship Some
Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet Is a trade product unit of use true Inferred relationship Some
Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet Is a Qlaira true Inferred relationship Some
Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet Is a estradiol valerate 2 mg + dienogest 3 mg tablet true Inferred relationship Some
Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet has manufactured dose form film-coated tablet false Inferred relationship Some
Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet has intended active ingredient dienogest true Inferred relationship Some 1862329708
Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet has Australian BoSS estradiol valerate true Inferred relationship Some 1906085032
Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet has Australian BoSS dienogest true Inferred relationship Some 1862329708
Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet has unit of use tablet true Inferred relationship Some 1906085033
Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet has intended active ingredient estradiol true Inferred relationship Some 1906085032
Inbound Relationships Type Active Source Characteristic Refinability Group
Qlaira, 84 tablets [3 x 28], blister pack has TPUU False Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet Inferred relationship Some
Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 28 has TPUU True Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet Inferred relationship Some 1
Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 28, blister pack has TPUU True Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet Inferred relationship Some 2
Qlaira, 84 tablets [3 x 28], blister pack has TPUU False Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet Inferred relationship Some
Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 has TPUU True Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet Inferred relationship Some 2
Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs has TPUU True Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet Inferred relationship Some 3

Reference Sets

Trade product unit of use reference set

Back to Start